Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Glucagon-Like Peptide 1 Receptor Agonists for Obesity: Efficacy, Side Effects, and Risks

Current Treatment Options in Gastroenterology(2024)10.1007/s11938-024-00452-6Source: DataRank Database

Glucagon-Like Peptide 1 Receptor Agonists for Obesity: Efficacy, Side Effects, and Risks is a research paper published in Current Treatment Options in Gastroenterology (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.13)OA: closedTopics (19)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Elif Tama ORCID,Maria D. Hurtado Andrade,Sanjana Thota-Kammili ORCID

Live enrichment

PubMed:19162232 OpenAlex:https://openalex.org/W4400289038

National Institutes of Health

Grant: K12-ARO84222

National Institutes of Health

Grant: 5K12AR084222-16

Mayo Clinic Building Interdisciplinary Research Careers in Women’s Health

FWCI

2.13

Citation Percentile

0.9%

Citation Trend

2025

2026

closedLicense: Springer Nature TDM

publisherhttps://link.springer.com/content/pdf/10.1007/s11938-024-00452-6.pdf

publisherhttps://link.springer.com/article/10.1007/s11938-024-00452-6/fulltext.html

journalhttps://doi.org/10.1007/s11938-024-00452-6

Fields of Study

Diabetes Treatment and ManagementPharmacology and Obesity TreatmentDiabetes Management and Research03 medical and health sciences0302 clinical medicine

Keywords

MedicineGlucagon-like peptide-1Glucagon-like peptide 1 receptorPharmacologyObesitySide effect (computer science)Internal medicineEndocrinologyReceptorBioinformaticsAgonistDiabetes mellitusType 2 diabetesBiology

Sustainable Development Goals

SDG 0: Zero hunger

Glucagon-Like Peptide 1 Receptor Agonists for Obesity: Efficacy, Side Effects, and Risks

FAIR Checklist

Authors (3)

Funding (2 grants)

Impact

Open Access

Topics